AVG.L

Avingtrans Plc
Avingtrans PLC - PDMR Dealings
26th March 2024, 11:15
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 3434I
Avingtrans PLC
26 March 2024
 

26 March 2024

 

Avingtrans plc

 

("Avingtrans", the "Company", or the "Group")

 

PDMR Dealings

 

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces dealings in its shares by certain PDMRs as detailed below:

 

On 25 March 2024, Stephen King & Austen Adams sold 5,400 and 110,000 ordinary shares of 5 pence each ("Ordinary Shares") at a price of 390.0 pence per Ordinary Share respectively.

 

Subsequently on 26 March 2024, Austen Adams purchased 5,166 Ordinary Shares into his ISA at a price of 387.0 pence per Ordinary Share.

 

As a result of the above activity, Stephen King & Austen Adams' interest in the Company's issued share capital are 411,938 and 158,301 Ordinary Shares respectively, representing 1.2% and 0.5% of the Company's enlarged share capital respectively.

 

 

 

Enquiries:

 

Avingtrans plc

01354 692 391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

 

Singer Capital Markets (Nominated Adviser and Broker)

020 7496 3000

Shaun Dobson

Alex Bond

Oliver Platts

 

 

 

IFC Advisory (Financial PR)

 

020 3934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

About Avingtrans plc: 

 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

 

Business units

 

Hayward Tyler - Luton, East Kilbride & Nottingham, UK, USA, China and India

 

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments. 

 

Energy Steel, Inc - Rochester Hills, Michigan, USA

 

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support. 

 

Stainless Metalcraft Ltd - Chatteris, UK

 

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems. 

 

Booth Industries - Bolton, UK

 

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast and explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above.

 

Ormandy Group - Bradford, UK

 

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products.

 

Composite Products Ltd - Buckingham, UK

 

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Adaptix Ltd - Oxford, UK

 

Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary applications amongst others. Commercialisation of this system (and others) is on-going.

 

Magnetica Ltd - Brisbane, Australia

 

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units: 

 

Scientific Magnetics - Abingdon, UK

 

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

 

Tecmag Inc - Houston, USA

 

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Steve King

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CFO

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each



Identification code

ISIN: GB0009188797

 



b)

 

Nature of the transaction

 

 

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)


Sale of Ordinary Shares

Price(s)

Volume(s)

390.00p

5,400

 

 

 

 







d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

25 March 2024

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Austen Adams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

MD, Process Solutions & Rotating Equipment

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each



Identification code

ISIN: GB0009188797

 



b)

 

Nature of the transaction

 

 

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)


Sale of Ordinary Shares

Price(s)

Volume(s)

390.00p

110,000

 

 

 

 


d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

25 March 2024

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Austen Adams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

MD, Process Solutions & Rotating Equipment

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p each



Identification code

ISIN: GB0009188797

 



b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

 

c)

 

Price(s) and volume(s)


Sale of Ordinary Shares

Price(s)

Volume(s)

387.00p

15,166

 

 

 

 


d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

26 March 2024

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGZFMVMGDZM]]>
TwitterFacebookLinkedIn